메뉴 건너뛰기




Volumn 34, Issue 11, 2004, Pages 759-765

Treatment with granulocyte colony-stimulating factor increases interleukin-1 receptor antagonist levels during engraftment following allogeneic stem-cell transplantation

Author keywords

Allogeneic; Engraftment; G CSF; IL 1ra; Stem cell transplantation

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

EID: 8744267075     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2004.01421.x     Document Type: Article
Times cited : (3)

References (58)
  • 1
    • 0025763425 scopus 로고
    • The clinical use of colony stimulating factors
    • Moore MAS. The clinical use of colony stimulating factors. Ann Rev Immunol 1991;9:159-83.
    • (1991) Ann Rev Immunol , vol.9 , pp. 159-183
    • Moore, M.A.S.1
  • 2
    • 0028556418 scopus 로고
    • The clinical utility of granulocyte colony-stimulating factor: Early achievement and future promise
    • Morstyn G, Foote M, Perkins D, Vincent M. The clinical utility of granulocyte colony-stimulating factor: early achievement and future promise. Stem Cells 1994;12 (Suppl. 1):213-27.
    • (1994) Stem Cells , vol.12 , Issue.SUPPL. 1 , pp. 213-227
    • Morstyn, G.1    Foote, M.2    Perkins, D.3    Vincent, M.4
  • 3
    • 0030844757 scopus 로고    scopus 로고
    • The role of granulocyte colony-stimulating factor in hematopoietic stem cell transplantation
    • Tabbara IA, Ghazal CD, Ghazal HH. The role of granulocyte colony-stimulating factor in hematopoietic stem cell transplantation. Cancer Invest 1997;15:353-7.
    • (1997) Cancer Invest , vol.15 , pp. 353-357
    • Tabbara, I.A.1    Ghazal, C.D.2    Ghazal, H.H.3
  • 4
    • 0028063675 scopus 로고
    • Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high-risk lymphoid malignancies
    • Stahel RA, Jost LM, Cerny T, Pichert G, Honegger H, Tobler A et al. Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high-risk lymphoid malignancies. J Clin Oncol 1994;12:1931-8.
    • (1994) J Clin Oncol , vol.12 , pp. 1931-1938
    • Stahel, R.A.1    Jost, L.M.2    Cerny, T.3    Pichert, G.4    Honegger, H.5    Tobler, A.6
  • 5
    • 0029008334 scopus 로고
    • Granulocyte colony-stimulating factor accelerates neutrophil engraftment following peripheral-blood stem-cell transplantation: A prospective, randomized trial
    • Klumpp TR, Mangan KF, Goldberg SL, Pearlman ES, Macdonald JS. Granulocyte colony-stimulating factor accelerates neutrophil engraftment following peripheral-blood stem-cell transplantation: a prospective, randomized trial. J Clin Oncol 1995;13:1323-7.
    • (1995) J Clin Oncol , vol.13 , pp. 1323-1327
    • Klumpp, T.R.1    Mangan, K.F.2    Goldberg, S.L.3    Pearlman, E.S.4    Macdonald, J.S.5
  • 6
    • 0031017172 scopus 로고    scopus 로고
    • Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral-blood stem-cell transplantation in patients with lymphoproliferative disorders: Evidence for clinical and economic benefit
    • McQuaker IG, Hunter AE, Pacey S, Haynes AP, Iqbal A, Russell NH. Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral-blood stem-cell transplantation in patients with lymphoproliferative disorders: evidence for clinical and economic benefit. J Clin Oncol 1997;15:451-7.
    • (1997) J Clin Oncol , vol.15 , pp. 451-457
    • McQuaker, I.G.1    Hunter, A.E.2    Pacey, S.3    Haynes, A.P.4    Iqbal, A.5    Russell, N.H.6
  • 8
    • 0032532624 scopus 로고    scopus 로고
    • Efficacy and costs of granulocyte colony-stimulating factor in allogeneic T-cell depleted bone marrow transplantation
    • Lee SJ, Weller E, Alyea EP, Ritz J, Soiffer RJ. Efficacy and costs of granulocyte colony-stimulating factor in allogeneic T-cell depleted bone marrow transplantation. Blood 1998;92:2725-9.
    • (1998) Blood , vol.92 , pp. 2725-2729
    • Lee, S.J.1    Weller, E.2    Alyea, E.P.3    Ritz, J.4    Soiffer, R.J.5
  • 9
    • 1442265964 scopus 로고    scopus 로고
    • Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: A study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
    • Ringden O, Labopin M, Gorin NC, Le Blanc K, Rocha V, Gluckman E et al. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. J Clin Oncol 2004;22:416-23.
    • (2004) J Clin Oncol , vol.22 , pp. 416-423
    • Ringden, O.1    Labopin, M.2    Gorin, N.C.3    Le Blanc, K.4    Rocha, V.5    Gluckman, E.6
  • 10
    • 0025618868 scopus 로고
    • Granulocyte colony-stimulating factor
    • Nicola NA. Granulocyte colony-stimulating factor. Immunol Series 1990;49:77-109.
    • (1990) Immunol Series , vol.49 , pp. 77-109
    • Nicola, N.A.1
  • 11
    • 0025885415 scopus 로고
    • Granulocyte colony-stimulating factor and its receptor
    • Demetri GD, Griffin JD. Granulocyte colony-stimulating factor and its receptor. Blood 1991;78:2791-808.
    • (1991) Blood , vol.78 , pp. 2791-2808
    • Demetri, G.D.1    Griffin, J.D.2
  • 12
    • 0027281568 scopus 로고
    • Granulocyte colony-stimulating factor down-regulates the surface expression of the human leucocyte adhesion molecule-1 on human neutrophils in vitro and in vivo
    • Ohsaka A, Saionji K, Sato N, Mori T, Ishimoto K, Inamatsu T. Granulocyte colony-stimulating factor down-regulates the surface expression of the human leucocyte adhesion molecule-1 on human neutrophils in vitro and in vivo. Br J Haematol 1993;84:574-80.
    • (1993) Br J Haematol , vol.84 , pp. 574-580
    • Ohsaka, A.1    Saionji, K.2    Sato, N.3    Mori, T.4    Ishimoto, K.5    Inamatsu, T.6
  • 13
    • 0024457849 scopus 로고
    • Recombinant human granulocyte colony-stimulating factor as an activator of human granulocytes: Potentiation of responses triggered by receptor-mediated agonists and stimulation of C3bi receptor expression and adherence
    • Yuo A, Kitagawa S, Ohsaka A, Ohta M, Miyazono K, Okabe T et al. Recombinant human granulocyte colony-stimulating factor as an activator of human granulocytes: potentiation of responses triggered by receptor-mediated agonists and stimulation of C3bi receptor expression and adherence. Blood 1989;74:2144-9.
    • (1989) Blood , vol.74 , pp. 2144-2149
    • Yuo, A.1    Kitagawa, S.2    Ohsaka, A.3    Ohta, M.4    Miyazono, K.5    Okabe, T.6
  • 14
    • 0027476531 scopus 로고
    • Granulocyte colony-stimulating factor induces hFc gamma RI (CD64 antigen)-positive neutrophils via an effect on myeloid precursor cells
    • Kerst JM, van de Winkel JG, Evans AH, de Haas M, Slaper-Cortenbach IC, de Wit TP et al. Granulocyte colony-stimulating factor induces hFc gamma RI (CD64 antigen)-positive neutrophils via an effect on myeloid precursor cells. Blood 1993;81:1457-64.
    • (1993) Blood , vol.81 , pp. 1457-1464
    • Kerst, J.M.1    Van De Winkel, J.G.2    Evans, A.H.3    De Haas, M.4    Slaper-Cortenbach, I.C.5    De Wit, T.P.6
  • 15
    • 0027482755 scopus 로고
    • Recombinant granulocyte colony-stimulating factor administration to healthy volunteers: Induction of immunophenotypically and functionally altered neutrophils via an effect on myeloid progenitor cells
    • Kerst JM, de Haas M, van de Schoot CE, Slaper-Cortenbach IC, von Kleijer M, von dem Borne AE et al. Recombinant granulocyte colony-stimulating factor administration to healthy volunteers: induction of immunophenotypically and functionally altered neutrophils via an effect on myeloid progenitor cells. Blood 1993;82:3265-72.
    • (1993) Blood , vol.82 , pp. 3265-3272
    • Kerst, J.M.1    De Haas, M.2    Van De Schoot, C.E.3    Slaper-Cortenbach, I.C.4    Von Kleijer, M.5    Von Dem Borne, A.E.6
  • 16
    • 0028131845 scopus 로고
    • Granulocyte colony-stimulating factor administration to healthy volunteers: Analysis of the immediate activating effects on circulating neutrophils
    • de Haas M, Kerst JM, van der Schoot CE, Calafat J, Hack CE, Nuijens JH et al. Granulocyte colony-stimulating factor administration to healthy volunteers: analysis of the immediate activating effects on circulating neutrophils. Blood 1994;84:3885-94.
    • (1994) Blood , vol.84 , pp. 3885-3894
    • De Haas, M.1    Kerst, J.M.2    Van Der Schoot, C.E.3    Calafat, J.4    Hack, C.E.5    Nuijens, J.H.6
  • 17
    • 0028946236 scopus 로고
    • Granulocyte colony-stimulating factor administration modulates the surface expression of effector cell molecules on human monocytes
    • Ohsaka A, Saionji K, Kuwaki T, Takeshima T, Igari J. Granulocyte colony-stimulating factor administration modulates the surface expression of effector cell molecules on human monocytes. Br J Haematol 1995;89:465-72.
    • (1995) Br J Haematol , vol.89 , pp. 465-472
    • Ohsaka, A.1    Saionji, K.2    Kuwaki, T.3    Takeshima, T.4    Igari, J.5
  • 18
    • 0031982524 scopus 로고    scopus 로고
    • Granulocyte colony-stimulating factor administration increases serum concentrations of soluble selectins
    • Ohsaka A, Saionji K, Igari J. Granulocyte colony-stimulating factor administration increases serum concentrations of soluble selectins. Br J Haematol 1998;100:66-9.
    • (1998) Br J Haematol , vol.100 , pp. 66-69
    • Ohsaka, A.1    Saionji, K.2    Igari, J.3
  • 19
    • 0028927105 scopus 로고
    • Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers
    • Hartung T, Docke WD, Gantner F, Krieger G, Sauer A, Stevens P et al. Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood 1995;85:2482-9.
    • (1995) Blood , vol.85 , pp. 2482-2489
    • Hartung, T.1    Docke, W.D.2    Gantner, F.3    Krieger, G.4    Sauer, A.5    Stevens, P.6
  • 20
    • 0030056892 scopus 로고    scopus 로고
    • Effects of granulocyte colony-stimulating factor on plasma cytokine and cytokine receptor levels and on the in vivo host response to endotoxin in healthy men
    • Pollmächer T, Korth C, Mullington J, Schreiber W, Sauer J, Vedder H et al. Effects of granulocyte colony-stimulating factor on plasma cytokine and cytokine receptor levels and on the in vivo host response to endotoxin in healthy men. Blood 1996;87:900-5.
    • (1996) Blood , vol.87 , pp. 900-905
    • Pollmächer, T.1    Korth, C.2    Mullington, J.3    Schreiber, W.4    Sauer, J.5    Vedder, H.6
  • 21
    • 0030874199 scopus 로고    scopus 로고
    • Modulation of cytokine release and neutrophil function by granulocyte colony-stimulating factor during endotoxemia in humans
    • Pajkrt D, Manten A, vanderPoll T, Tiel-van Buul MMC, Jansen J, Wouterten CJ et al. Modulation of cytokine release and neutrophil function by granulocyte colony-stimulating factor during endotoxemia in humans. Blood 1997;90:1415-24.
    • (1997) Blood , vol.90 , pp. 1415-1424
    • Pajkrt, D.1    Manten, A.2    VanderPoll, T.3    Tiel-Van Buul, M.M.C.4    Jansen, J.5    Wouterten, C.J.6
  • 22
    • 0030822084 scopus 로고    scopus 로고
    • Inhibition of lymphocyte blastogenic response in healthy donors treated with recombinant human granulocyte colony-stimulating factor (rhG-CSF): Possible role of lactoferrin and interleukin-1 receptor antagonist
    • Rutella S, Rumi C, Testa U, Sica S, Teofili L, Martucci R et al. Inhibition of lymphocyte blastogenic response in healthy donors treated with recombinant human granulocyte colony-stimulating factor (rhG-CSF): possible role of lactoferrin and interleukin-1 receptor antagonist. Bone Marrow Transplant 1997;20:355-64.
    • (1997) Bone Marrow Transplant , vol.20 , pp. 355-364
    • Rutella, S.1    Rumi, C.2    Testa, U.3    Sica, S.4    Teofili, L.5    Martucci, R.6
  • 23
    • 0029147465 scopus 로고
    • Interleukin-1 receptor antagonist
    • Lennard AC. Interleukin-1 receptor antagonist. Crit Rev Immunol 1995;15:77-105.
    • (1995) Crit Rev Immunol , vol.15 , pp. 77-105
    • Lennard, A.C.1
  • 25
    • 0031831906 scopus 로고    scopus 로고
    • Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist
    • Dinarello CA. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int Rev Immunol 1998;16:457-99.
    • (1998) Int Rev Immunol , vol.16 , pp. 457-499
    • Dinarello, C.A.1
  • 26
    • 0028018567 scopus 로고
    • Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: A randomized, open-label, placebo-controlled multicenter trial
    • The IL-1ra Sepsis Syndrome Study Group
    • Fisher CJ, Slotman GJ, Opal SM, Fribble JP, Bone RC, Emmanuel G et al. Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial. The IL-1ra Sepsis Syndrome Study Group. Crit Care Med 1994;22:12-21.
    • (1994) Crit Care Med , vol.22 , pp. 12-21
    • Fisher, C.J.1    Slotman, G.J.2    Opal, S.M.3    Fribble, J.P.4    Bone, R.C.5    Emmanuel, G.6
  • 28
    • 0037111657 scopus 로고    scopus 로고
    • Interleukin-1 blockade does not prevent acute graft versus host disease. Results of a randomized, double blind, placebo-controlled trial of interleukin 1 receptor antagonist in allogeneic bone marrow Transplantation
    • Antin JH, Weisdorf D, Neuberg D, Nicklow R, Clouthier S, Lee SJ et al. Interleukin-1 blockade does not prevent acute graft versus host disease. Results of a randomized, double blind, placebo-controlled trial of interleukin 1 receptor antagonist in allogeneic bone marrow Transplantation. Blood 2002;100:3479-82.
    • (2002) Blood , vol.100 , pp. 3479-3482
    • Antin, J.H.1    Weisdorf, D.2    Neuberg, D.3    Nicklow, R.4    Clouthier, S.5    Lee, S.J.6
  • 29
    • 0028067822 scopus 로고
    • Regulation of cytokine expression by interferon-α in human bone marrow stromal cell: Inhibition of hematopoietic growth factors and induction of interleukin-1 receptor antagonist
    • Aman MJ, Keller U, Derigs G, Mohamadzadeh M, Huber C, Peschel C. Regulation of cytokine expression by interferon-α in human bone marrow stromal cell: inhibition of hematopoietic growth factors and induction of interleukin-1 receptor antagonist. Blood 1994;84:4142-50.
    • (1994) Blood , vol.84 , pp. 4142-4150
    • Aman, M.J.1    Keller, U.2    Derigs, G.3    Mohamadzadeh, M.4    Huber, C.5    Peschel, C.6
  • 30
    • 0028073119 scopus 로고
    • Aplastic anemia: Analysis of stromal cell function in long-term marrow cultures
    • Holmberg LA, Seidel K, Leisenring W, Torok-Storb B. Aplastic anemia: analysis of stromal cell function in long-term marrow cultures. Blood 1994;84:3685-90.
    • (1994) Blood , vol.84 , pp. 3685-3690
    • Holmberg, L.A.1    Seidel, K.2    Leisenring, W.3    Torok-Storb, B.4
  • 31
    • 0028947458 scopus 로고
    • Recombinant human interleukin-1 receptor antagonist protects early myeloid progenitors in a murine model of cyclophosphamide-induced myelotoxicity
    • Chudgar UH, Rundus CH, Peterson VM. Recombinant human interleukin-1 receptor antagonist protects early myeloid progenitors in a murine model of cyclophosphamide-induced myelotoxicity. Blood 1995;85:2393-401.
    • (1995) Blood , vol.85 , pp. 2393-2401
    • Chudgar, U.H.1    Rundus, C.H.2    Peterson, V.M.3
  • 32
    • 0026330925 scopus 로고
    • Modulation of cell proliferation and cytokine production in acute myeloblastic leukemia by interleukin-1 receptor antagonist and lack of its expression by leukemic cells
    • Rimbaldi A, Torcia M, Bettoni S, Vannier E, Barbui T, Shaw AR et al. Modulation of cell proliferation and cytokine production in acute myeloblastic leukemia by interleukin-1 receptor antagonist and lack of its expression by leukemic cells. Blood 1991;78:3248-53.
    • (1991) Blood , vol.78 , pp. 3248-3253
    • Rimbaldi, A.1    Torcia, M.2    Bettoni, S.3    Vannier, E.4    Barbui, T.5    Shaw, A.R.6
  • 33
    • 0026732573 scopus 로고
    • Inhibition of acute myelogenous leukemia blast proliferation by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors
    • Estrov Z, Kurzrock R, Estey E, Wetzler M, Ferrajoli A, Harris D et al. Inhibition of acute myelogenous leukemia blast proliferation by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors. Blood 1992;79:1838-945.
    • (1992) Blood , vol.79 , pp. 1838-1945
    • Estrov, Z.1    Kurzrock, R.2    Estey, E.3    Wetzler, M.4    Ferrajoli, A.5    Harris, D.6
  • 34
    • 0029998207 scopus 로고    scopus 로고
    • Interleukin 1 receptor antagonsit (IL1RA) in acute leukemia: IL1RA is both secreted spontaneously by myelogenous leukaemia blasts and is part of the acute phase reaction in patients with chemotherapy-induced leucopenia
    • Bruserod O, Aasen I, Akselsen PE, Bergheim J, Rasmussen G, Nesthus I. Interleukin 1 receptor antagonsit (IL1RA) in acute leukemia: IL1RA is both secreted spontaneously by myelogenous leukaemia blasts and is part of the acute phase reaction in patients with chemotherapy-induced leucopenia. Eur J Haematol 1996;57:87-95.
    • (1996) Eur J Haematol , vol.57 , pp. 87-95
    • Bruserod, O.1    Aasen, I.2    Akselsen, P.E.3    Bergheim, J.4    Rasmussen, G.5    Nesthus, I.6
  • 35
    • 0025946285 scopus 로고
    • Suppression of chronic myeloid leukemia colony growth by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors: A novel application for inhibitors of IL-1 activity
    • Estrov Z, Kurzrock R, Wetzler M, Kantarjian H, Blake M, Harris D et al. Suppression of chronic myeloid leukemia colony growth by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors: a novel application for inhibitors of IL-1 activity. Blood 1991;78:1476-86.
    • (1991) Blood , vol.78 , pp. 1476-1486
    • Estrov, Z.1    Kurzrock, R.2    Wetzler, M.3    Kantarjian, H.4    Blake, M.5    Harris, D.6
  • 36
    • 0030824872 scopus 로고    scopus 로고
    • Busulfan/cyclophosphamide in volunteer unrelated donor (VUD) BMT: Excellent feasibility and low incidence of treatment-related toxicity
    • Bertz H, Potthoff K, Mertelsmann R, Finke J. Busulfan/ cyclophosphamide in volunteer unrelated donor (VUD) BMT: excellent feasibility and low incidence of treatment-related toxicity. Bone Marrow Transplant 1997;19:1169-73.
    • (1997) Bone Marrow Transplant , vol.19 , pp. 1169-1173
    • Bertz, H.1    Potthoff, K.2    Mertelsmann, R.3    Finke, J.4
  • 37
    • 0032969258 scopus 로고    scopus 로고
    • Influence of recombinant human granulocyte colony-stimulating factor (filgrastim) on hematopoietic recovery and outcome following allogeneic bone marrow transplantation (BMT) from volunteer unrelated donors
    • Berger C, Bertz H, Schmoor C, Behringer D, Potthoff K, Mertelsmann R et al. Influence of recombinant human granulocyte colony-stimulating factor (filgrastim) on hematopoietic recovery and outcome following allogeneic bone marrow transplantation (BMT) from volunteer unrelated donors. Bone Marrow Transplant 1999;23:983-90.
    • (1999) Bone Marrow Transplant , vol.23 , pp. 983-990
    • Berger, C.1    Bertz, H.2    Schmoor, C.3    Behringer, D.4    Potthoff, K.5    Mertelsmann, R.6
  • 38
    • 0028926373 scopus 로고
    • Calculating correlation coefficients with repeated observations: Part 1 - Correlation within subjects
    • Bland JM, Altman DG. Calculating correlation coefficients with repeated observations: Part 1 - correlation within subjects. Br Med J 1995;310:446.
    • (1995) Br Med J , vol.310 , pp. 446
    • Bland, J.M.1    Altman, D.G.2
  • 39
    • 0028927937 scopus 로고
    • Calculating correlation coefficients with repeated observations: Part 2 - Correlation between subjects
    • Bland JM, Altman DG. Calculating correlation coefficients with repeated observations: Part 2 - correlation between subjects. Br Med J 1995;310:633.
    • (1995) Br Med J , vol.310 , pp. 633
    • Bland, J.M.1    Altman, D.G.2
  • 40
    • 0030961241 scopus 로고    scopus 로고
    • Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein
    • Gabay C, Smith MF, Eidlen D, Arend WP. Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein. J Clin Invest 1997;99:2930-40.
    • (1997) J Clin Invest , vol.99 , pp. 2930-2940
    • Gabay, C.1    Smith, M.F.2    Eidlen, D.3    Arend, W.P.4
  • 41
    • 0028172866 scopus 로고
    • Altered levels of interleukin-1b and interleukin-1 receptor antagonist in chronic myelogenous leukemia: Clinical and prognostic correlates
    • Wetzler M, Kurzrock R, Estrov Z, Kantarjian H, Gisslinger H, Underbrink M et al. Altered levels of interleukin-1b and interleukin-1 receptor antagonist in chronic myelogenous leukemia: clinical and prognostic correlates. Blood 1994;84:3142-7.
    • (1994) Blood , vol.84 , pp. 3142-3147
    • Wetzler, M.1    Kurzrock, R.2    Estrov, Z.3    Kantarjian, H.4    Gisslinger, H.5    Underbrink, M.6
  • 42
    • 0027518593 scopus 로고
    • Expression of interleukin-1 receptor antagonist (IL-1ra) by human circulating polymorphnuclear cells
    • Re F, Mengozzi F, Muzio M, Dinarello CA, Mantovani A, Colotta F. Expression of interleukin-1 receptor antagonist (IL-1ra) by human circulating polymorphnuclear cells. Eur J Immunol 1993;23:570-3.
    • (1993) Eur J Immunol , vol.23 , pp. 570-573
    • Re, F.1    Mengozzi, F.2    Muzio, M.3    Dinarello, C.A.4    Mantovani, A.5    Colotta, F.6
  • 43
    • 0028218242 scopus 로고
    • Peripheral blood neutrophil production of interleukin-1 receptor antagonist and interleukin-1 beta
    • Malyak M, Smith MF, Abel AA, Arend WP. Peripheral blood neutrophil production of interleukin-1 receptor antagonist and interleukin-1 beta. J Clin Immunol 1994;14:20-30.
    • (1994) J Clin Immunol , vol.14 , pp. 20-30
    • Malyak, M.1    Smith, M.F.2    Abel, A.A.3    Arend, W.P.4
  • 44
    • 0026717870 scopus 로고
    • Human neutrophils produce high levels of the interleukin 1 receptor antagonist in response to granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha
    • McColl SR, Paquin R, Menard C, Beaulieu AD. Human neutrophils produce high levels of the interleukin 1 receptor antagonist in response to granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha. J Exp Med 1992;176:593-8.
    • (1992) J Exp Med , vol.176 , pp. 593-598
    • McColl, S.R.1    Paquin, R.2    Menard, C.3    Beaulieu, A.D.4
  • 45
    • 0030614515 scopus 로고    scopus 로고
    • Endogenous interleukin 1 receptor antagonist during human bone marrow transplantation: Increased levels during graft-versus-host disease, during infectious complications, and after immunoglobulin therapy
    • Schwaighofer H, Oberhuber G, Hebart H, Einsele H, Herold M, Nachbaur D et al. Endogenous interleukin 1 receptor antagonist during human bone marrow transplantation: increased levels during graft-versus-host disease, during infectious complications, and after immunoglobulin therapy. Transplantation 1997;63:52-66.
    • (1997) Transplantation , vol.63 , pp. 52-66
    • Schwaighofer, H.1    Oberhuber, G.2    Hebart, H.3    Einsele, H.4    Herold, M.5    Nachbaur, D.6
  • 46
    • 0032532205 scopus 로고    scopus 로고
    • Serum cytokine levels after HLA-identical bone marrow transplantation
    • Liem LM, vanHouwelingen HC, Goulmy E. Serum cytokine levels after HLA-identical bone marrow transplantation. Transplantation 1998;66:863-71.
    • (1998) Transplantation , vol.66 , pp. 863-871
    • Liem, L.M.1    VanHouwelingen, H.C.2    Goulmy, E.3
  • 47
    • 0029768091 scopus 로고    scopus 로고
    • Functions of interleukin 1 receptor antagonist in gene knock out and overproducing mice
    • Hirsch E, Irikura VM, Paul SM, Hirsh D. Functions of interleukin 1 receptor antagonist in gene knock out and overproducing mice. Proc Natl Acad Sci USA 1996;93:11008-13.
    • (1996) Proc Natl Acad Sci USA , vol.93 , pp. 11008-11013
    • Hirsch, E.1    Irikura, V.M.2    Paul, S.M.3    Hirsh, D.4
  • 49
  • 50
    • 0023600013 scopus 로고
    • Synergy of interleukin-1 and granulocyte colony-stimulating factor, in vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice
    • Moore MA, Warren DJ. Synergy of interleukin-1 and granulocyte colony-stimulating factor, in vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice. Proc Natl Acad Sci 1987;84:7134-8.
    • (1987) Proc Natl Acad Sci , vol.84 , pp. 7134-7138
    • Moore, M.A.1    Warren, D.J.2
  • 51
    • 0023905482 scopus 로고
    • Protective, restorative, and therapeutic properties of recombinant human TT-1 in rodent models
    • Castelli MP, Black PL, Schneider M, Pennington R, Abe F, Talmadge JE. Protective, restorative, and therapeutic properties of recombinant human TT-1 in rodent models. J Immunol 1988;140:3830-7.
    • (1988) J Immunol , vol.140 , pp. 3830-3837
    • Castelli, M.P.1    Black, P.L.2    Schneider, M.3    Pennington, R.4    Abe, F.5    Talmadge, J.E.6
  • 52
    • 0025805859 scopus 로고
    • In vivo administration of granulocyte colony-stimulating factor (G- CSF), granulocyte-macrophage CSF, interleukin-1 (IL-1), and IL-4, alone and in combination, after allogeneic murine hematopoietic stem cell transplantation
    • Atkinson K, Matias C, Guiffre A, Seymour R, Cooley M, Biggs J et al. In vivo administration of granulocyte colony-stimulating factor (G- CSF), granulocyte-macrophage CSF, interleukin-1 (IL-1), and IL-4, alone and in combination, after allogeneic murine hematopoietic stem cell transplantation. Blood 1991;77:1376-82.
    • (1991) Blood , vol.77 , pp. 1376-1382
    • Atkinson, K.1    Matias, C.2    Guiffre, A.3    Seymour, R.4    Cooley, M.5    Biggs, J.6
  • 53
    • 0028178474 scopus 로고
    • Phase I study of recombinant interleukin-1 beta in patients undergoing autologous bone marrow transplant for acute myelogenous leukemia
    • Nemunaitis J, Appelbaum FR, Lilleby K, Buhles WC, Rosenfeld C, Zeigler ZR et al. Phase I study of recombinant interleukin-1 beta in patients undergoing autologous bone marrow transplant for acute myelogenous leukemia. Blood 1994;83:3473-9.
    • (1994) Blood , vol.83 , pp. 3473-3479
    • Nemunaitis, J.1    Appelbaum, F.R.2    Lilleby, K.3    Buhles, W.C.4    Rosenfeld, C.5    Zeigler, Z.R.6
  • 54
    • 0028169280 scopus 로고
    • Interleukin-1 alpha administered after autologous transplantation: A phase I/II clinical trial
    • Weisdorf D, Katsanis E, Verfaillie C, Ramsay NK, Haake R, Garrison L et al. Interleukin-1 alpha administered after autologous transplantation: a phase I/II clinical trial. Blood 1994;84:2044-9.
    • (1994) Blood , vol.84 , pp. 2044-2049
    • Weisdorf, D.1    Katsanis, E.2    Verfaillie, C.3    Ramsay, N.K.4    Haake, R.5    Garrison, L.6
  • 55
    • 0031045211 scopus 로고    scopus 로고
    • A phase I trial of recombinant human interleukin-1 beta (OCT-43) following high-dose chemotherapy and autologous bone marrow transplantation
    • Elkordy M, Crump M, Vredenburgh JJ, Petros WP, Hussein A, Rubin P et al. A phase I trial of recombinant human interleukin-1 beta (OCT-43) following high-dose chemotherapy and autologous bone marrow transplantation. Bone Marrow Transplant 1997;19:315-22.
    • (1997) Bone Marrow Transplant , vol.19 , pp. 315-322
    • Elkordy, M.1    Crump, M.2    Vredenburgh, J.J.3    Petros, W.P.4    Hussein, A.5    Rubin, P.6
  • 56
    • 0030611646 scopus 로고    scopus 로고
    • The pattern of interleukin-1β (IL-1β) and its modulating agent IL-1 receptor antagonist and IL-1 soluble receptor type II in acute meningococcal infections
    • van Deuren M, van der Ven-Jongekrijg J, Vannier E, van Dalen R, Pesman G, Bartelink AKM et al. The pattern of interleukin-1β (IL-1β) and its modulating agent IL-1 receptor antagonist and IL-1 soluble receptor type II in acute meningococcal infections. Blood 1997;90:1101-8.
    • (1997) Blood , vol.90 , pp. 1101-1108
    • Van Deuren, M.1    Van Der Ven-Jongekrijg, J.2    Vannier, E.3    Van Dalen, R.4    Pesman, G.5    Bartelink, A.K.M.6
  • 58
    • 0033556353 scopus 로고    scopus 로고
    • Granulocyte colony-stimulating factor to prevent the progression of systemic nonresponsiveness in systemic inflammatory response syndrome and sepsis
    • Weiss M, Moldawer LL, Schneider EM. Granulocyte colony-stimulating factor to prevent the progression of systemic nonresponsiveness in systemic inflammatory response syndrome and sepsis. Blood 1999;93:425-39.
    • (1999) Blood , vol.93 , pp. 425-439
    • Weiss, M.1    Moldawer, L.L.2    Schneider, E.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.